CQDM embodies collaborative research in the biopharmaceutical sector. We facilitate public-private partnerships and promote multidisciplinary collaborations across Quebec and Canada. Our support goes well beyond financial aid: our dedicated team assists companies and researchers in planning and executing their innovation projects. We help life sciences companies grow and increase their competitiveness, contributing to a prosperous ecosystem that fosters biopharmaceutical innovations beneficial for Quebecers and Canadians.
Mission
CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy.
Vision
We will increase Canada’s economic growth and wealth and improve the health of our population by contributing to a sustainable national life sciences innovation ecosystem as a long-term outcome.
Our Values
- Collaboration: Contribute to maintaining an environment conducive to the development of the industry in a spirit of solidarity and openness to the different points of view and skills of all stakeholders
- Leadership: Proactive participation and commitment to the dynamic development of the industry
- Excellence: Rigor, quality and integrity in our actions
- Creativity: A way to see possibilities where there seems to be none. A state of mind from which innovation emerges
- Diversity: A richness for our ecosystem requires a great diversity of points of view, opinion and way of doing things
Our Value Proposition
As an established partner of federal and provincial governments, industry, and academia, CQDM deploys R&D funding programs that focus on accelerating the translation of innovation into socio-economic outcomes and health benefits for our population.
Our value proposition is articulated as follows:
- A unique business-led and purpose-driven collaborative model that brings together the private and the public sector to translate innovation into economic outcomes and health benefits
- Privileged interactions with global pharma and other private sector organizations
- A market pull approach to address the priority needs of the Canadian private sector
- A collaborative model that leverages a large pool of resources and expertise
- Financial leverage to de-risk early-stage innovation and attract private investments